Skip to content

From the American College of Rheumatology

Rheumatology for Primary Care
  • Symptoms
  • Diseases
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Chronic Recurrent Multifocal Osteomyelitis
    • Crystalline Arthropathies
    • Drug or Medication-induced Rheumatic Diseases
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura (HSP)
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Idiopathic Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease (MCTD)
    • Multisystem Inflammatory Syndrome in Children (MIS-C)
    • Myositis
    • Polyarteritis Nodosa
    • Polymyalgia Rheumatica
    • Rheumatoid Arthritis (RA)
    • Sarcoidosis
    • Sicca/Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus (SLE)
    • Systemic Sclerosis
  • Diagnostics
  • Case Studies
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Crystalline Arthropathies
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Inflammatory Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease
    • Polyarteritis Nodosa
    • Polymalgia Rheumatica
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sicca/Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
  • Meds
    • Treatment Guides
    • Addressing Patient Fears
    • Treatment Considerations
    • Major Categories of Rheumatology Medications
  • Resources
    • Vaccination Considerations – Pediatrics
    • Vaccination Considerations – Adults

Treatment Guides

Home » Treatment Guides
Treatment Guides

Medication Guides

Have a patient taking a biologic, antiresorptive, or other medication used to treat rheumatic disease or considering prescribing one? The medication guides below provide streamlined information on the administration of many of the most commonly used treatments in rheumatology.

  • Abaloparatide (Tymlos)
  • Abatacept (Orencia)
  • Adalimumab (Humira)
  • Aledronate (Fosamax)
  • Anakinra (Kineret)
  • Anifrolumab-fnia (Saphnelo)
  • Apremilast (Otezla)
  • Baricitinib (Olumiant)
  • Belimumab (Benlysta)
  • Canakinumab (Ilaris)
  • Certolizumab (Cimzia)
  • Corticosteroids
  • Cyclophosphamide (Cytoxan)
  • Denosumab (Prolia)
  • Etanercept (Enbrel)
  • Golimumab (Simponi, Simponi Aria)
  • Guselkumab (Tremfya)
  • Hydroxychloroquine (Plaquenil)
  • Ibandronate (Boniva)
  • Infliximab (Remicade)
  • IVIG (intravenous immune globulin)
  • Ixekizumab (Taltz)
  • Leflunomide (Arava)
  • Methotrexate (Otrexup, Resuvo)
  • Mycophenolate (Cellcept, Myfortic)
  • Pegloticase (Krystexxa)
  • Risankizumab-rzaa (Skyrizi)
  • Risedronate (Actonel)
  • Rituximab (Rituxan)
  • Romosozumab (Evenity)
  • Sarilumab (Kevzara)
  • Secukinumab (Cosentyx)
  • Sulfasalazine (Azulfidine)
  • Tocilizumab (Actemra)
  • Tofacitinib (Xeljanz)
  • Upadacitinib (Rinvoq)
  • Ustekinumab (Stelara)
  • Zoledronic Acid (Reclast)
Tami Bonnett-Admi2024-02-20T18:38:14+00:00

Treatment Fact Sheets

Visit ACR’s website to view information on some of the most common medications and therapies used to treat rheumatic disease, including how they work, common dosages, safety tips, possible side effects, and risks.

Fact sheets are downloadable/printable PDFs that you can provide to your patients, as well.
View Fact sheets

ACR Information

About ACR

ACR Contacts

Website Feedback

What do you think about the website? We would love to hear your feedback.

Provide Feedback

Authors

This product was funded by a medical grant from Pfizer. The content was written by a physician work group. See Authors.

© Copyright American College of Rheumatology 2026 | All rights reserved | See ACR Policies

Page load link
Go to Top